RESEARCH PAPER
Trend of HIV and tuberculosis co-epidemics in different regions of World Health Organization during 2003-2017
 
More details
Hide details
1
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
 
2
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran
 
3
Health Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
 
4
Department of Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran
 
5
Department of Public Health, School of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran
 
 
Submission date: 2019-06-23
 
 
Final revision date: 2019-08-07
 
 
Acceptance date: 2019-10-09
 
 
Publication date: 2020-10-09
 
 
HIV & AIDS Review 2020;19(3):167-171
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The co-infection of human immunodeficiency virus (HIV)/tuberculosis (TB) is one of the main public health problems globally. Due to the importance of this problem, the aim of the current study was to determine the trend of TB patients with known HIV status and TB patients who are HIV-positive in different regions of World Health Organization (WHO) from 2003 to 2017.

Material and methods:
In the current ecological study, the needed information about the HIV/TB cases were extracted from the WHO website. To assess the trend of changes over the time of understudy variables, the Spearman correlation coefficient and figures were used. The statistical significance level for this study was considered as p = 0.05. All analysis was performed by Excel 2010 and SPSS version 22.

Results:
The percentage of TB patients with known HIV status during 2003-2017 had an increasing trend in all parts of the WHO regions. The HIV/TB co-infection showed a decreasing tendency for all regions, except Europe. Furthermore, the trend of HIV/TB co-infection in Europe was increasing during the studied period.

Conclusions:
Given that the diseases are global, not only countries should expand education and investing in HIV and tuberculosis control, but also international community organizations should attempt to identify and treat the infected patients in underdeveloped and developing countries.

 
REFERENCES (20)
1.
Gao L, Zhou F, Li X, Jin Q. HIV/TB co-infection in mainland China:.
 
2.
a meta-analysis. PLoS One 2010; 5: e10736.
 
3.
Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42-46.
 
4.
Tabatabaee H, Afsar-Kazerooni P, Alimohamadi Y, et al. Intensified or routine case finding for pulmonary tuberculosis among HIV-infected patients: which is better? J Health Sci Surveill Syst 2015; 3: 13-19.
 
5.
Alimohamadi Y, Tabatabaee H, Afsarkazerooni P, Vahedi S, Enaami M, Teimourizad A. Epidemiologic characteristics of HIV-positive patients referring to behavioral diseases consultation center in Shiraz, Iran. Med J Islam Repub Iran 2014; 28: 147.
 
6.
Toossi Z, Mayanja‐Kizza H, Hirsch C, et al. Impact of tuberculosis (TB) on HIV‐1 activity in dually infected patients. Clin Exp Immunol 2001; 123: 233-238.
 
7.
Haseli N, Esmaeelzadeh F, Ghahramani F, Alimohamadi Y, Haya-.
 
8.
ti R, Mahboubi M. Health-related quality of life and its related factors in HIV+ patients referred to Shiraz Behavioral Counseling Center, Iran in 2012. Med J Islam Repub Iran 2014; 28: 13.
 
9.
Trinh Q, Nguyen H, Nguyen V, Nguyen T, Sintchenko V, Marais B.
 
10.
Tuberculosis and HIV co-infection – focus on the Asia-Pacific region. Int J Infect Dis 2015; 32: 170-178.
 
11.
Sharma S, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res 2005; 121: 550-567.
 
12.
Silva CJ, Torres DF. A TB-HIV/AIDS coinfection model and optimal control treatment. arXiv: 1501.03322.
 
13.
Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjørn B. The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health 2008; 8: 266.
 
14.
Gelaw YA, Williams G, Magalhães RJS, Gilks CF, Assefa Y. HIV prevalence among tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis. AIDS Behav 2019; 23: 1561-1575.
 
15.
Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One 2013; 8: e64915.
 
16.
Manjareeka M, Nanda S. Prevalence of HIV infection among tuberculosis patients in Eastern India. J Infect Public Health 2013; 6: 358-362.
 
17.
Pennap G, Makpa S, Ogbu S. Sero-prevalence of HIV infection among tuberculosis patients in a rural tuberculosis referral clinic in northern Nigeria. Pan Afr Med J 2010; 5: 22.
 
18.
Pimpin L, Drumright LN, Kruijshaar ME, et al. Tuberculosis and HIV co-infection in European Union and European Economic Area countries. Eur Respir J 2011; 38: 1382-1392.
 
19.
Tavares AM, Fronteira I, Couto I, et al. HIV and tuberculosis co-.
 
20.
infection among migrants in Europe: a systematic review on the prevalence, incidence and mortality. PLoS One 2017; 12: e0185526.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top